Medication adherence and quality of life among type-2 diabetes mellitus patients in India

Table 2 Quality of life scores and clinical characteristics of the study participants

Clinical characteristics	n (%)277	Physical domain	Psychological domain	Social domain	Environmental domain	Overall perception of QoL	Overall perception of health
Duration of T2DM, yr
1-5	150 (54.2)	57.19 ± 14.61	52.77 ± 15.54	70.98 ± 12.06	57.03 ± 12.39	68.67 ± 14.91	64.13 ± 15.77
6-10	90 (32.5)	54.98 ± 14.91	51.07 ± 14.11	67.74 ± 17.02	57.12 ± 12.21	66.67 ± 14.06	63.78 ± 16.93
11-15	31 (11.2)	60.35 ± 19.86	56.06 ± 18.94	70.42 ± 14.96	57.16 ± 10.03	69.03 ± 15.35	63.23 ± 19.39
> 15	06 (2.2)	59.33 ± 15.86	52.17 ± 14.69	67.67 ± 12.13	60.67 ± 03.61	73.33 ± 16.33	66.67 ± 16.33
Drug used
Metformin	80 (28.9)	56.27 ± 14.55	51.00 ± 13.68	69.77 ± 14.09	56.46 ± 11.91	67.75 ± 13.31	64.25 ± 15.49
Glimepiride	66 (23.8)	61.20 ± 15.54	56.64 ± 15.21	71.44 ± 12.32	56.38 ± 12.10	71.82 ± 14.45	66.36 ± 16.14
Other OHA	131 (47.3)	55.05 ± 15.53	51.49 ± 16.37	68.98 ± 15.12	57.97 ± 11.90	66.56 ± 15.38	62.60 ± 17.26
Chronic comorbid illness
Hypertension	115 (41.5)	56.31 ± 15.46	51.94 ± 15.54	67.27 ± 15.44	56.81 ± 10.94	65.91 ± 14.74	61.74 ± 17.28
Thyroid	151 (54.5)	57.62 ± 15.48	53.54 ± 15.01	71.87 ± 13.11	57.39 ± 12.87	69.93 ± 14.21	65.70 ± 15.89
CAD	11 (4.00)	52.36 ± 13.91	46.00 ± 20.00	67.64 ± 10.76	57.54 ± 08.85	67.27 ± 18.49	63.64 ± 15.01

CAD: Coronary artery disease; DM: Diabetes mellitus; OHA: Oral hypoglycemic agent, QoL: Quality of life; T2DM: Type-2 diabetes mellitus. Data are n (%) or mean ± SD.